Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Integra Lifesciences Q3 Adj. EPS $0.54 Beats $0.43 Estimate, Sales $402.062M Miss $414.256M Estimate

Author: Benzinga Newsdesk | October 30, 2025 05:00am
Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.43 by 24.14 percent. This is a 31.71 percent increase over earnings of $0.41 per share from the same period last year. The company reported quarterly sales of $402.062 million which missed the analyst consensus estimate of $414.256 million by 2.94 percent. This is a 5.57 percent increase over sales of $380.834 million the same period last year.

Posted In: IART


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist